Indeed, the ability to eliminate B16F10 tumors, a model for melanoma, in vivo upon vaccination with wild-type or Cav1−/− DCs decreases in the latter, pointing to defects in CCR7 chemokine receptor and probably integrin activation (Oyarce et al., 2017). The gene discussed is CCR7; the disease is melanoma.